iBio (IBIO) Gains from Investment Securities (2020 - 2023)
iBio (IBIO) posted quarterly Gains from Investment Securities of $113000.0 for Q1 2023, up 9.71% year-over-year from $103000.0 in Q1 2022, and up 213.89% quarter-over-quarter from $36000.0 in Q4 2022.
iBio (IBIO) Gains from Investment Securities (2020 - 2023) Analysis & Trends
iBio (IBIO) has reported Gains from Investment Securities for 4 consecutive years, with $113000.0 the latest figure, recorded in Q1 2023.
- In Q1 2023, Gains from Investment Securities rose 9.71% year-over-year to $113000.0; the TTM figure through Sep 2023 stood at $149000.0 (down 6.29% YoY), while the FY2023 annual figure was $159000.0, up 6.0% from the prior year.
- Gains from Investment Securities advanced to $113000.0 in Q1 2023 per IBIO's latest filing, from $36000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $113000.0 in Q1 2023 and bottomed at -$7000.0 in Q2 2021.
- Historically, Gains from Investment Securities has averaged $33800.0 across 4 years, with a median of $19500.0 in 2020.
- Annual changes were most pronounced in 2022 — Gains from Investment Securities jumped 900.0% — and 2023, when it advanced 9.71%.
- iBio's Gains from Investment Securities stood at $20000.0 in 2020, then jumped by 35.0% to $27000.0 in 2021, then jumped by 33.33% to $36000.0 in 2022, then jumped by 213.89% to $113000.0 in 2023.
- Business Quant data shows IBIO's Gains from Investment Securities at $113000.0 in Q1 2023, $36000.0 in Q4 2022, and $10000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 113,000.00 |
| Mar 31, 2023 | 113,000.00 |
| Dec 31, 2022 | 36,000.00 |
| Dec 31, 2022 | 36,000.00 |
| Sep 30, 2022 | 10,000.00 |
| Sep 30, 2022 | 10,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Mar 31, 2022 | 103,000.00 |
| Mar 31, 2022 | 103,000.00 |
| Dec 31, 2021 | 27,000.00 |
| Dec 31, 2021 | 27,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Jun 30, 2021 | -7,000.00 |
| Jun 30, 2021 | -7,000.00 |
| Mar 31, 2021 | 16,000.00 |
| Mar 31, 2021 | 16,000.00 |
| Dec 31, 2020 | 20,000.00 |
| Dec 31, 2020 | 20,000.00 |